Hepatocellular Carcinoma: from Liquid Biopsy to Immunotherapy

Zhouhong Ge

Hepatocellular Carcinoma: from Liquid Biopsy to Immunotherapy

Zhouhong Ge^*

^*Corresponding author for this work

Gastroenterology & Hepatology

Research output: Types of Thesis › Doctoral Thesis › Internal

5 Downloads (Pure)

Abstract

In this thesis we aim to optimize existing immunotherapy for hepatocellular carcinoma (HCC) with a strong emphasis on checkpoint inhibition. We aim to detect tumor-associated mutations in paired circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) in a western cohort of HCC patients.

Original language	English
Awarding Institution	Erasmus University Rotterdam
Supervisors/Advisors	Peppelenbosch, Maikel, Supervisor Sprengers, Dave, Co-supervisor Kraan, Jaco, Co-supervisor
Award date	1 Jun 2021
Place of Publication	Rotterdam
Print ISBNs	978-94-6416-629-3
Publication status	Published - 1 Jun 2021

Bibliographical note

The research was funded by:
- China Scholarship Council
- Nederlandse Vereniging Voor Gastro-enterologie

Access to Document

dissertation Zhouhong GeFinal published version, 8.48 MBLicence: Unspecified

Cite this

@phdthesis{d84b7fc8c4b647938c1e647c126d50ed,

title = "Hepatocellular Carcinoma: from Liquid Biopsy to Immunotherapy",

abstract = "In this thesis we aim to optimize existing immunotherapy for hepatocellular carcinoma (HCC) with a strong emphasis on checkpoint inhibition. We aim to detect tumor-associated mutations in paired circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) in a western cohort of HCC patients.",

author = "Zhouhong Ge",

note = "The research was funded by: - China Scholarship Council - Nederlandse Vereniging Voor Gastro-enterologie",

year = "2021",

month = jun,

day = "1",

language = "English",

isbn = "978-94-6416-629-3",

school = "Erasmus University Rotterdam",

}

TY - THES

T1 - Hepatocellular Carcinoma

T2 - from Liquid Biopsy to Immunotherapy

AU - Ge, Zhouhong

N1 - The research was funded by: - China Scholarship Council - Nederlandse Vereniging Voor Gastro-enterologie

PY - 2021/6/1

Y1 - 2021/6/1

N2 - In this thesis we aim to optimize existing immunotherapy for hepatocellular carcinoma (HCC) with a strong emphasis on checkpoint inhibition. We aim to detect tumor-associated mutations in paired circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) in a western cohort of HCC patients.

AB - In this thesis we aim to optimize existing immunotherapy for hepatocellular carcinoma (HCC) with a strong emphasis on checkpoint inhibition. We aim to detect tumor-associated mutations in paired circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) in a western cohort of HCC patients.

UR - http://hdl.handle.net/1765/135609

M3 - Doctoral Thesis

SN - 978-94-6416-629-3

CY - Rotterdam

ER -

Hepatocellular Carcinoma: from Liquid Biopsy to Immunotherapy

Abstract

Bibliographical note

Access to Document

Other files and links

Fingerprint

Cite this